{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T06:46:28Z","timestamp":1791960388324,"version":"4.3.4"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T00:00:00Z","timestamp":1791763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T00:00:00Z","timestamp":1791763200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["High Blood Press Cardiovasc Prev"],"DOI":"10.1007\/s40292-026-00827-z","type":"journal-article","created":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T17:36:21Z","timestamp":1791826581000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Real-World Adherence to Dihydropyridine Calcium-Channel Blockers: A Pharmacoepidemiologic Study"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-2770-3608","authenticated-orcid":false,"given":"Marco","family":"Capacci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Rivasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Degli Esposti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Fumagalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe Dario","family":"Testa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Leonetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Giannessi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Ferri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Ungar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niccol\u00f2","family":"Marchionni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,12]]},"reference":[{"key":"827_CR1","doi-asserted-by":"publisher","unstructured":"Zhou B, Carrillo-Larco RM, Danaei G, Riley LM, Paciorek CJ, Stevens GA, Gregg EW,Bennett JE, Solomon B, Singleton RK, Sophiea MK, Iurilli MLC, Lhoste VPF, Cowan MJ,Savin S, Woodward M, Balanova Y, Cifkova R, Damasceno A, Elliott P, Farzadfar F, He J, Ikeda N, Kengne AP, Khang YH, Kim HC, Laxmaiah A, Lin HH, Maira PM, Miranda JJ,Neuhauser H, Sundstr\u00f6m J, Varghese C, Widyahening IS, Zdrojewski T, Ezzati M, Abarca-G\u00f3mez L, Abdeen ZA, Abdul Rahim HF, Abu-Rmeileh NM, Acosta-Cazares B, Adams RJ, Aekplakorn W, Afsana K, Afzal S, Agdeppa IA, Aghazadeh-Attari J, Aguilar-Salinas CA, Agyemang C, Ahmad NA, Ahmadi A, Ahmadi N, Ahmadi N, Ahmadizar F, Ahmed SH, Ahrens W, Ajlouni K, Al-Raddadi R, Alarouj M, AlBuhairan F, AlDhukair S, Ali MM, Alkandari A, Alkerwi A, Allin K, Aly E, Amarapurkar DN, Amougou N, Amouyel P, Andersen LB, Anderssen SA,Anjana RM, Ansari-Moghaddam A, Ansong D, Aounallah-Skhiri H, Ara\u00fajo J, Ariansen I,Aris T, Arku RE, Arlappa N, Aryal KK, Aspelund T, Assah FK, Assun\u00e7\u00e3o MCF, Auvinen J, Avdi\u0107ov\u00e1 M, Azevedo A, Azimi-Nezhad M, Azizi F, Azmin M, Babu B V., Bahijri S,Balakrishna N, Bamoshmoosh M, Banach M, Banadinovi\u0107 M, Bandosz P, Banegas JR, Baran J, Barbagallo CM, Barcel\u00f3 A, Barkat A, Barreto M, Barros AJD, Barros MVG, Bartosiewicz A, Basit A, Bastos JLD, Bata I, Batieha AM, Batyrbek A, Baur LA, Beaglehole R, Belavendra A, Romdhane H Ben, Benet M, Benson LS, Berkinbayev S, Bernabe-Ortiz A, Bernotiene G, Bettiol H, Bezerra J, Bhagyalaxmi A, Bhargava SK, Bia D, Biasch K, Lele ECB, Bikbov MM, Bista B, Bjerregaard P, Bjertness E, Bjertness MB, Bj\u00f6rkelund C, Bloch K V., Blokstra A, Bo S, Bobak M, Boeing H, Boggia JG, Boissonnet CP, Bojesen SE, Bongard V, Bonilla-Vargas A, Braeckman L, Bruno G, Bueno-De-Mesquita HB, Burns C, Cardoso VC, Cervantes-Loaiza M, Chadjigeorgiou CA, Chamukuttan S, Chan AW, Chan Q, Chaturvedi HK, Chaturvedi N,Chee ML, Chen CJ, Chen F, Chen H, Chen S, Chen Z, Cheng CY, Cheraghian B, Dekkaki IC, Chetrit A, Chien KL, Chiolero A, Chiou ST, Chirita-Emandi A, Chirlaque MD, Cho B, Christensen K, Christofaro DG, Chudek J, Cinteza E, Claessens F, Clarke J, Clays E, Cohen E, Concin H, Cooper C, Coppinger TC, Costanzo S, Cottel D, Cowell C, Craig CL, Crampin AC, Crujeiras AB, Cruz JJ, Csilla S, Cui L, Cureau F V., Cuschieri S,D\u2019Arrigo G, d\u2019Orsi E, Dallongeville J, Dankner R, Dantoft TM, Dauchet L, Davletov K, De Backer G, De Bacquer D, De Curtis A, de Gaetano G, De Henauw S, de Oliveira PD, De Ridder D, De Smedt D, Deepa M, Deev AD, DeGennaro V, Delisle H, Demarest S,Dennison E, Deschamps V, Dhimal M, Di Castelnuovo AF, Dias-Da-Costa JS, Diaz A, Dickerson TT, Dika Z, Djalalinia S, Do HTP, Dobson AJ, Donfrancesco C, Donoso SP, D\u00f6ring A,Dorobantu M, D\u00f6rr M, Doua K, Dragano N, Drygas W, Duante CA, Duboz P, Duda RB, Dulskiene V, Dushpanova A, D\u017eakula A, Dzerve V, Dziankowska-Zaborszczyk E, Eddie R, Eftekhar E, Eggertsen R, Eghtesad S, Eiben G, Ekelund U, El-Khateeb M, El Ati J, Eldemire-Shearer D, Eliasen M, Elosua R, Erasmus RT, Erbel R, Erem C, Eriksen L, Eriksson JG, Escobedo-De la Pe\u00f1a J, Eslami S, Esmaeili A, Evans A, Faeh D, Fakhretdinova AA, Fall CH, Faramarzi E, Farjam M, Fattahi MR, Fawwad A, Felix-Redondo FJ, Felix SB, Ferguson TS, Fernandes RA, Fern\u00e1ndez-Berg\u00e9s D, Ferrante D, Ferrao T, Ferrari M, Ferrario MM, Ferreccio C,Ferreira HS, Ferrer E, Ferrieres J, Figueir\u00f3 TH, Fink G, Fischer K, Foo LH, Forsner M, Fouad HM, Francis DK, do Carmo Franco M, Frikke-Schmidt R, Frontera G, Fuchs FD,Fuchs SC, Fujita Y, Fumihiko M, Furdela V, Furer A, Furusawa T, Gaciong Z, Galbarczyk A, Galenkamp H, Galvano F, Gao J, Gao P, Garcia-De-la-Hera M, Garcia P, Gareta D,Garnett SP, Gaspoz JM, Gasull M, Gazzinelli A, Gehring U, Geleijnse JM, George R,Ghanbari A, Ghasemi E, Gheorghe-Fronea OF, Ghimire A, Gialluisi A, Giampaoli S, Gieger C, Gill TK, Giovannelli J, Gironella G, Giwercman A, Gkiouras K, Goldberg M, Goldsmith RA, Gomez LF, Gomula A, Gon\u00e7alves Cordeiro da Silva B, Gon\u00e7alves H, Gon\u00e7alves M, Gonzalez-Chica DA, Gonzalez-Gross M, Gonz\u00e1lez-Rivas JP, Gonz\u00e1lez-Villalpando C, Gonz\u00e1lez-Villalpando ME, Gonzalez AR, Gorbea MB, Gottrand F, Graff-Iversen S, Grafnetter D, Grajda A, Grammatikopoulou MG, Gregor RD, Grodzicki T, Grosso G, Gruden G, Gu D, Guan OP, Gudmundsson EF, Gudnason V, Guerrero R, Guessous I, Guimaraes AL, Gulliford MC, Gunnlaugsdottir J, Gunter MJ,Gupta PC, Gupta R, Gureje O, Gurzkowska B, Gutierrez L, Gutzwiller F, Ha S, Hadaegh F, Haghshenas R, Hakimi H, Halkj\u00e6r J, Hambleton IR, Hamzeh B, Hange D, Hanif AAM,Hantunen S, Hao J, Hardman CM, Hari Kumar R, Hashemi-Shahri SM, Hata J, Haugsgjerd T, Hayes AJ, He Y, Heier M, Hendriks ME, Henrique RDS, Henriques A, Hernandez Cadena L, Herqutanto, Herrala S, Heshmat R, Hill AG, Ho SY, Ho SC, Hobbs M, Holdsworth M,Homayounfar R, Horasan Dinc G, Horimoto ARVR, Hormiga CM, Horta BL, Houti L, Howitt C, Htay TT, Htet AS, Htike MMT, Hu Y, Huerta JM, Huhtaniemi IT, Huiart L, Huisman M, Husseini AS, Huybrechts I, Hwalla N, Iacoviello L, Iannone AG, Ibrahim MM, Ibrahim Wong N, Ikram MA, Iotova V, Irazola VE, Ishida T, Isiguzo GC, Islam M, Islam SMS,Iwasaki M, Jackson RT, Jacobs JM, Jaddou HY, Jafar T, James K, Jamrozik K, Janszky I, Janus E, Jarvelin MR, Jasienska G, Jelakovi\u0107 A, Jelakovi\u0107 B, Jennings G, Jha AK,Jiang CQ, Jimenez RO, J\u00f6ckel KH, Joffres M, Johansson M, Jokelainen JJ, Jonas JB,J\u00f8rgensen T, Joshi P, Joukar F, J\u00f3\u017awiak J, Juolevi A, Jurak G, Jure\u0161a V, Kaaks R,Kafatos A, Kajantie EO, Kalmatayeva Z, Kalpourtzi N, Kalter-Leibovici O, Kampmann FB, Kannan S, Karaglani E, K\u00e5rhus LL, Karki KB, Katibeh M, Katz J, Kauhanen J, Kaur P, Kavousi M, Kazakbaeva GM, Keil U, Boker LK, Kein\u00e4nen-Kiukaanniemi S, Kelishadi R, Kemper HCG, Keramati M, Kerimkulova A, Kersting M, Key T, Khader YS, Khalili D,Khaw KT, Kheiri B, Kheradmand M, Khosravi A, Kiechl-Kohlendorfer U, Kiechl S, Killewo J, Kim DW, Kim J, Klakk H, Klimek M, Klumbiene J, Knoflach M, Kolle E, Kolsteren P,Kontto JP, Korpelainen R, Korrovits P, Kos J, Koskinen S, Kouda K, Kowlessur S, Koziel S, Kratenova J, Kriaucioniene V, Kristensen PL, Krokstad S, Kromhout D, Kruger HS,Kubinova R, Kuciene R, Kujala UM, Kulaga Z, Krishna Kumar R, Kurjata P, Kusuma YS,Kutsenko V, Kuulasmaa K, Kyobutungi C, Laatikainen T, Lachat C, Laid Y, Lam TH, Landrove O, Lanska V, Lappas G, Larijani B, Latt TS, Le Coroller G, Le Nguyen Bao K, Le TD,Lee J, Lee J, Lehmann N, Lehtim\u00e4ki T, Lemogoum D, Levitt NS, Li Y, Lilly CL, Lim WY,Lima-Costa MF, Lin X, Lin YT, Lind L, Lingam V, Linneberg A, Lissner L, Litwin M,Lo WC, Loit HM, Lopez-Garcia E, Lopez T, Lotufo PA, Lozano JE, Lovren\u010di\u0107 IL, Lukrafka JL, Luksiene D, Lundqvist A, Lundqvist R, Lunet N, Lustigov\u00e1 M, Luszczki E, Ma G,Ma J, Machado-Coelho GLL, Machado-Rodrigues AM, Macia E, Macieira LM, Madar AA, Maggi S, Magliano DJ, Magriplis E, Mahasampath G, Maire B, Majer M, Makdisse M, Malekzadeh F, Malekzadeh R, Malhotra R, Rao KM, Malyutina SK, Maniego L V., Manios Y, Mann JI,Mansour-Ghanaei F, Manzato E, Marcil A, Margozzini P, M\u00e5rild SB, Marinovi\u0107 Glavi\u0107 M, Marques-Vidal P, Marques LP, Marrugat J, Martorell R, Mascarenhas LP, Matasin M,Mathiesen EB, Mathur P, Matijasevich A, Matlosz P, Matsha TE, Mavrogianni C, Mbanya JCN, Mc Donald Posso AJ, McFarlane SR, McGarvey ST, McLachlan S, McLean RM, McLean SB, McNulty BA, Mediene Benchekor S, Medzioniene J, Mehdipour P, Mehlig K, Mehrparvar AH, Meirhaeghe A, Meisinger C, Montano CM, Menezes AMB, Menon GR, Mereke A, Meshram II, Metspalu A, Meyer HE, Mi J, Michels N, Mikkel K, Milkowska K, Miller JC, Minderico CS, Mini GK, Mirjalili MR, Mirrakhimov E, Mi\u0161igoj-Durakovi\u0107 M, Modesti PA, Moghaddam SS, Mohajer B, Mohamed MK, Mohamed SF, Mohammad K, Mohammadi MR, Mohammadi Z, Mohammadifard N, Mohammadpourhodki R, Mohan V, Mohanna S, Mohd Yusoff MF, Mohebbi I, Mohebi F, Moitry M, M\u00f8llehave LT, Moln\u00e1r D, Momenan A, Mondo CK, Monterrubio-Flores E, Monyeki KDK,Moon JS, Moosazadeh M, Moreira LB, Morejon A, Moreno LA, Morgan K, Moschonis G, Mossakowska M, Mostafa A, Mostafavi SA, Mota J, Motlagh ME, Motta J, Moura-Dos-Santos MA, Mridha MK, Msyamboza KP, Mu TT, Muhihi AJ, Muiesan ML, M\u00fcller-Nurasyid M, Murphy N, Mursu J, Musa KI, Milanovi\u0107 SM, Musil V, Mustafa N, Nabipour I, Naderimagham S, Nagel G,Naidu BM, Najafi F, Nakamura H, N\u00e1me\u0161n\u00e1 J, Nang EEK, Nangia VB, Narake S, Ndiaye NC,Neal WA, Nejatizadeh A, Nenko I, Neovius M, Nguyen CT, Nguyen ND, Nguyen Q V., Nguyen QN, Nieto-Mart\u00ednez RE, Niiranen TJ, Nikitin YP, Ninomiya T, Nishtar S, Njelekela MA,Noale M, Noboa OA, Noorbala AA, Norat T, Nordendahl M, Nordestgaard BG, Noto D, Nowak-Szczepanska N, Nsour M Al, Nunes B, O\u2019Neill TW, O\u2019Reilly D, Ochimana C, Oda E, Odili AN, Oh K,Ohara K, Ohtsuka R, Olinto MTA, Oliveira IO, Omar MA, Onat A, Ong SK, Ono LM, Ordunez P, Ornelas R, Ortiz PJ, Osmond C, Ostojic SM, Ostovar A, Otero JA, Overvad K, Owusu-Dabo E, Paccaud FM, Padez C, Pahomova E, de Paiva KM, Paj\u0105k A, Palli D, Palmieri L, Pan WH, Panda-Jonas S, Panza F, Paoli M, Papandreou D, Park SW, Park S, Parnell WR, Parsaeian M, Pasquet P, Patel ND, Pavlyshyn H, Pe\u0107in I, Pednekar MS, Pedro JM, Peer N, Peixoto SV, Peltonen M, Pereira AC, Peres KGDA, Peres MA, Peters A, Petkeviciene J, Peykari N, Pham ST, Pichardo RN, Pigeot I, Pikhart H, Pilav A, Pilotto L, Pitakaka F, Piwonska A, Pizarro A, Pedro Plans-Rubi\u00f3, Pola\u0161ek O, Porta M, Poudyal A, Pourfarzi F, Pourshams A, Poustchi H, Pradeepa R, Price AJ, Price JF, Providencia R, Puhakka SE, Puiu M,Punab M, Qasrawi RF, Qorbani M, Queiroz D, Quoc Bao T, Radi\u0107 I, Radisauskas R, Rahimikazerooni S, Rahman M, Raitakari O, Raj M, Rakhimova EM, Rao SR, Ramachandran A, Ramos E, Rampal L, Rampal S, Rangel Reina DA, Rarra V, Ricardo Rech C, Redon J, Reganit PFM, Regecov\u00e1 V, Revilla L, Rezaianzadeh A, Ribeiro R, Riboli E, Richter A, Rigo F, Rinke de Wit TF, Ritti-Dias RM, Robitaille C, Rodr\u00edguez-Artalejo F, Rodriguez-Perez MDC, Rodr\u00edguez-Villamizar LA, Roggenbuck U, Rojas-Martinez R, Romaguera D, Romeo EL, Rosengren A, Roy JGR, Rubinstein A, Ruidavets JB, Ruiz-Betancourt BS, Ruiz-Castell M, Rusakova IA, Russo P, Rutkowski M, Sabanayagam C, Sabbaghi H, Sachdev HS, Sadjadi A, Safarpour AR, Safi S, Safiri S, Saidi O, Sakarya S, Saki N, Salanave B, Salazar Martinez E, Salmer\u00f3n D, Salomaa V, Salonen JT, Salvetti M, S\u00e1nchez-Abanto J, Sans S, Santos DA, Santos IS, Santos LC, Santos MP, Santos R, Saramies JL, Sardinha LB, Sarganas G, Sarrafzadegan N, Sathish T, Saum KU, Savva S, Sawada N, Sbaraini M, Scazufca M, Schaan BD, Schargrodsky H,Schipf S, Schmidt CO, Schnohr P, Sch\u00f6ttker B, Schramm S, Schultsz C, Schutte AE, Sebert S, Sein AA, Sen A, Senbanjo IO, Sepanlou SG, Servais J, Shalnova SA, Shamah-Levy T,Shamshirgaran M, Shanthirani CS, Sharafkhah M, Sharma SK, Shaw JE, Shayanrad A, Shayesteh AA, Shi Z, Shibuya K, Shimizu-Furusawa H, Shin DW, Shirani M, Shiri R, Shrestha N,Si-Ramlee K, Siani A, Siantar R, Sibai AM, Silva CRDM, Santos Silva DA, Simon M, Simons J, Simons LA, Sj\u00f6str\u00f6m M, Slowikowska-Hilczer J, Slusarczyk P, Smeeth L, So HK, Soares FC, Sobngwi E, S\u00f6derberg S, Soemantri A, Sofat R, Solfrizzi V, Somi MH, Sonestedt E, Song Y, S\u00f8rensen TIA, S\u00f8rgjerd EP, Sori\u0107 M, Sossa J\u00e9rome C, Soumar\u00e9 A, Sparboe-Nilsen B, Sparrenberger K, Staessen JA, Starc G, Stavreski B, Steene-Johannessen J, Stehle P, Stein AD, Stergiou GS, Stessman J, Stieber J, St\u00f6ckl D, Stocks T, Stokwiszewski J, Stronks K, Strufaldi MW, Suka M, Sun CA, Sung YT, Suriyawongpaisal P, Sy RG, Syddall HE, Sylva RC, Szklo M, Shyong Tai E, Tammesoo ML, Tamosiunas A, Tan EJ, Tang X, Tanser F, Tao Y, Tarawneh MR, Tarqui-Mamani CB, Taylor A, Taylor J, Tebar WR, Tell GS, Tello T, Tham YC, Thankappan KR, Theobald H, Theodoridis X, Thijs L, Thinggaard M, Thomas N, Thorand B, Thuesen BH, Timmermans EJ, Tjandrarini DH, Tjonneland A, Toft U, Tolonen HK, Tolstrup JS, Topbas M, Top\u00f3r-Madry R, Tormo MJ, Tornaritis MJ, Torrent M, Torres-Collado L, Touloumi G, Traissac P, Triantafyllou A, Trichopoulos D, Trichopoulou A, Trinh OTH, Trivedi A, Tshepo L, Tsugane S, Tuliakova AM, Tulloch-Reid MK, Tullu F, Tuomainen TP, Tuomilehto J, Turley ML, Twig G, Tynelius P, Tzourio C, Ueda P, Ugel E, Ulmer H, Uusitalo HMT, Valdivia G, Valvi D, van Dam RM, van den Born BJ, Van der Heyden J, van der Schouw YT, Van Herck K, Van Minh H, Van Schoor NM, van Valkengoed IGM,van Zutphen EM, Vanderschueren D, Vanuzzo D, Varbo A, Vasan SK, Vega T, Veidebaum T, Velasquez-Melendez G, Veronesi G, Verschuren WMM, Verstraeten R, Victora CG, Viet L, Villalpando S, Vineis P, Vioque J, Virtanen JK, Visvikis-Siest S, Viswanathan B,Vlasoff T, Vollenweider P, Voutilainen A, Wade AN, Walton J, Wambiya EOA, Wan Bebakar WM, Wan Mohamud WN, Wanderley RDS, Wang MD, Wang N, Wang Q, Wang X, Wang YX, Wang YW, Wannamethee SG, Wareham N, Wei W, Weres A, Werner B, Whincup PH, Widhalm K, Wiecek A, Wilks RJ, Willeit J, Willeit P, Williams EA, Wilsgaard T, Wojtyniak B, Wong-McClure RA, Wong A, Wong TY, Woo J, Wu FC, Wu S, Wyszynska J, Xu H, Xu L, Yaacob NA, Yan W,Yang L, Yang X, Yang Y, Yasuharu T, Ye X, Yiallouros PK, Yoosefi M, Yoshihara A, You SL, Younger-Coleman NO, Yusoff AF, Zainuddin AA, Zakavi SR, Zamani F, Zambon S, Zampelas A, Zapata ME, Zaw KK, Zejglicova K, Zeljkovic Vrkic T, Zeng Y, Zhang L, Zhang ZY,Zhao D, Zhao MH, Zhen S, Zheng Y, Zholdin B, Zhu D, Zins M, Zitt E, Zocalo Y, Zoghlami N, Zu\u00f1iga Cisneros J. Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet. 2021;398(10304):957\u201380. https:\/\/doi.org\/10.1016\/S0140-6736(21)01330-1.\u00a0PubMed PMID: 34450083.","DOI":"10.1016\/S0140-6736(21)01330-1"},{"issue":"16","key":"827_CR2","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1161\/CIRCULATIONAHA.108.830299","volume":"120","author":"G Mazzaglia","year":"2009","unstructured":"Mazzaglia G, Ambrosioni E, Alacqua M, Filippi A, Sessa E, Immordino V, Borghi C, Brignoli O, Caputi AP, Cricelli C, Mantovani LG. Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients. Circulation. 2009;120(16):1598\u2013605. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.108.830299. PubMed PMID: 19805653.","journal-title":"Circulation"},{"issue":"7557","key":"827_CR3","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1136\/BMJ.38875.675486.55","volume":"333","author":"SH Simpson","year":"2006","unstructured":"Simpson SH, Eurich DT, Majumdar SR, Padwal RS, Tsuyuki RT, Varney J, Johnson JA. A meta-analysis of the association between adherence to drug therapy and mortality. BMJ. 2006;333(7557):15. https:\/\/doi.org\/10.1136\/BMJ.38875.675486.55. PubMed PMID: 16790458.","journal-title":"BMJ"},{"issue":"4","key":"827_CR4","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1136\/heartjnl-2013-304111","volume":"100","author":"A Briasoulis","year":"2014","unstructured":"Briasoulis A, Agarwal V, Tousoulis D, Stefanadis C. Effects of antihypertensive treatment in patients over 65 years of age: a meta-analysis of randomised controlled studies. Heart. 2014;100(4):317\u201323. https:\/\/doi.org\/10.1136\/heartjnl-2013-304111 . PubMed PMID: 23813846.","journal-title":"Heart"},{"issue":"18","key":"827_CR5","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1056\/NEJMOA0801369","volume":"358","author":"NS Beckett","year":"2008","unstructured":"Beckett NS, Peters R, Fletcher AE, Staessen JA, Liu L, Dumitrascu D, Stoyanovsky V, Antikainen RL, Nikitin Y, Anderson C, Belhani A, Forette F, Rajkumar C, Thijs L, Banya W, Bulpitt CJ. Treatment of hypertension in patients 80 years of age or older. N Engl J Med. 2008;358(18):1887\u201398. https:\/\/doi.org\/10.1056\/NEJMOA0801369 . PubMed PMID: 18378519.","journal-title":"N Engl J Med"},{"issue":"1","key":"827_CR6","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s40292-018-0290","volume":"26","author":"R Del Pinto","year":"2019","unstructured":"Del Pinto R, Ferri C. Hypertension management at older age: an update. High Blood Press Cardiovasc Prev. 2019;26(1):27\u201336. https:\/\/doi.org\/10.1007\/s40292-018-0290-. z PubMed PMID: 30467638.","journal-title":"High Blood Press Cardiovasc Prev"},{"issue":"7","key":"827_CR7","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1097\/hjh.0000000000001323","volume":"35","author":"G Corrao","year":"2017","unstructured":"Corrao G, Rea F, Monzio Compagnoni M, Merlino L, Mancia G. Protective effects of antihypertensive treatment in patients aged 85 years or older. J Hypertens. 2017;35(7):1432\u201341. https:\/\/doi.org\/10.1097\/hjh.0000000000001323 . PubMed PMID: 28319595.","journal-title":"J Hypertens"},{"issue":"17","key":"827_CR8","doi-asserted-by":"publisher","first-page":"26582","DOI":"10.1161\/JAHA.122.026582","volume":"11","author":"EKP Lee","year":"2022","unstructured":"Lee EKP, Poon P, Yip BHK, Bo Y, Zhu MT, Yu CP, Ngai ACH, Wong MCS, Wong SYS. Global Burden, Regional Differences, Trends, and Health Consequences of Medication Nonadherence for Hypertension During 2010 to 2020: A Meta-Analysis Involving 27 Million Patients. J Am Heart Assoc. 2022;11(17):26582. https:\/\/doi.org\/10.1161\/JAHA.122.026582 . PubMed PMID: 36056737.","journal-title":"J Am Heart Assoc"},{"key":"827_CR9","doi-asserted-by":"publisher","unstructured":"Vrijens B, De Geest S, Hughes DA, Przemyslaw K, Demonceau J, Ruppar T, Dobbels F, Fargher E, Morrison V, Lewek P, Matyjaszczyk M, Mshelia C, Clyne W, Aronson JK, Urquhart J. A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol. 2012;73(5):691\u2013705. https:\/\/doi.org\/10.1111\/J.1365-2125.2012.04167.X, PubMed PMID: 22486599.","DOI":"10.1111\/J.1365-2125.2012.04167.X"},{"issue":"7653","key":"827_CR10","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1136\/BMJ.39553","volume":"336","author":"B Vrijens","year":"2008","unstructured":"Vrijens B, Vincze G, Kristanto P, Urquhart J, Burnier M. Adherence to prescribed antihypertensive drug treatments: Longitudinal study of electronically compiled dosing histories. BMJ. 2008;336(7653):1114\u20137. https:\/\/doi.org\/10.1136\/BMJ.39553. .670231.25, PubMed PMID: 18480115.","journal-title":"BMJ"},{"issue":"4","key":"827_CR11","doi-asserted-by":"publisher","first-page":"304","DOI":"10.4065\/MCP.2010.0575","volume":"86","author":"MT Brown","year":"2011","unstructured":"Brown MT, Bussell JK. Medication adherence: WHO cares? Mayo Clin Proc. 2011;86(4):304\u201314. https:\/\/doi.org\/10.4065\/MCP.2010.0575. PubMed PMID: 21389250.","journal-title":"Mayo Clin Proc"},{"key":"827_CR12","unstructured":"World Health Organization. Adherence to long-term therapies: evidence for action. World Health Organization. 2003. Available from: https:\/\/iris.who.int\/bitstream\/handle\/10665\/42682\/9241545992.pdf.\u00a0[cited 2025 Jun 19]."},{"issue":"8","key":"827_CR13","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1592\/phco.21.11.940.34520","volume":"21","author":"SD Ross","year":"2001","unstructured":"Ross SD, Akhras KS, Zhang S, Rozinsky M, Nalysnyk L. Discontinuation of antihypertensive drugs due to adverse events: a systematic review and meta-analysis. Pharmacotherapy. 2001;21(8):940\u201353. PubMed PMID: 11718500.","journal-title":"Pharmacotherapy"},{"issue":"1","key":"827_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/S40264-023-01366-5","volume":"47","author":"C Micale","year":"2023","unstructured":"Micale C, Golder S, O\u2019Connor K, Weissenbacher D, Gross R, Hennessy S, Gonzalez-Hernandez G. Patient-Reported Reasons for Antihypertensive Medication Change: A Quantitative Study Using Social Media. Drug Saf 2023. 2023;47(1):1. https:\/\/doi.org\/10.1007\/S40264-023-01366-5 . PubMed PMID: 37995049.","journal-title":"Drug Saf 2023"},{"key":"827_CR15","doi-asserted-by":"publisher","unstructured":"Zhu J, Chen N, Zhou M, Guo J, Zhu C, Zhou J, Ma M, He L. Calcium channel blockers versus other classes of drugs for hypertension. Cochrane Database Syst Reviews. 2022;2022(1). https:\/\/doi.org\/10.1002\/14651858.CD003654.PUB6 . PubMed PMID: 35000192.","DOI":"10.1002\/14651858.CD003654.PUB6"},{"issue":"3","key":"827_CR16","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1097\/HJH.0000000000000067","volume":"32","author":"C De Ciuceis","year":"2014","unstructured":"De Ciuceis C, Salvetti M, Rossini C, Muiesan ML, Paini A, Duse S, La Boria E, Semeraro F, Cancarini A, Rosei CA, Sarkar A, Ruggeri G, Caimi L, Ricotta D, Rizzoni D, Rosei EA. Effect of antihypertensive treatment on microvascular structure, central blood pressure and oxidative stress in patients with mild essential hypertension. J Hypertens. 2014;32(3):565\u201374. 10.1097. \/HJH.0000000000000067, PubMed PMID: 24378999.","journal-title":"J Hypertens"},{"issue":"6","key":"827_CR17","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1080\/08037051.2016.1184495","volume":"25","author":"C De Ciuceis","year":"2016","unstructured":"De Ciuceis C, Rossini C, Tincani A, Air\u00f2 P, Scarsi M, Agabiti-Rosei C, Ruggeri G, Caimi L, Ricotta D, Agabiti-Rosei E, Rizzoni D. Effect of antihypertensive treatment with lercanidipine on endothelial progenitor cells and inflammation in patients with mild to moderate essential hypertension. Blood Press. 2016;25(6):337\u201343. .1184495, PubMed PMID: 27195656.","journal-title":"Blood Press"},{"key":"827_CR18","doi-asserted-by":"publisher","unstructured":"Guo Z, Tian E, Chen S, Wang J, Chen J, Kong W, Crans DC, Lu Y, Zhang S. Lercanidipine\u2019s Antioxidative Effect Prevents Noise-Induced Hearing Loss. Antioxidants. 2024;13:327. 2024;13(3):327. https:\/\/doi.org\/10.3390\/ANTIOX13030327.","DOI":"10.3390\/ANTIOX13030327"},{"issue":"7","key":"827_CR19","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1517\/13543784.8.7.1043","volume":"8","author":"PA Meredith","year":"1999","unstructured":"Meredith PA. Lercanidipine: a novel lipophilic dihydropyridine calcium antagonist with long duration of action and high vascular selectivity. Expert Opin Investig Drugs. 1999;8(7):1043\u201362. https:\/\/doi.org\/10.1517\/13543784.8.7.1043.","journal-title":"Expert Opin Investig Drugs"},{"issue":"11","key":"827_CR20","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1016\/S0895-7061","volume":"15","author":"G Leonetti","year":"2002","unstructured":"Leonetti G, Magnani B, Pessina AC, Rappelli A, Trimarco B, Zanchetti A. Tolerability of long-term treatment with lercanidipine versus amlodipine and lacidipine in elderly hypertensives. Am J Hypertens. 2002;15(11):932\u201340. https:\/\/doi.org\/10.1016\/S0895-7061. )03000-5, PubMed PMID: 12441211.","journal-title":"Am J Hypertens"},{"issue":"3","key":"827_CR21","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0167-4943","volume":"37","author":"A Cherubini","year":"2003","unstructured":"Cherubini A, Fabris F, Ferrari E, Cucinotta D, Incalzi RA, Senin U. Comparative effects of lercanidipine, lacidipine, and nifedipine gastrointestinal therapeutic system on blood pressure and heart rate in elderly hypertensive patients: The ELderly and LErcanidipine (ELLE) study. Arch Gerontol Geriatr. 2003;37(3):203\u201312. https:\/\/doi.org\/10.1016\/S0167-4943. (03)00047-5 PubMed PMID: 14511846.","journal-title":"Arch Gerontol Geriatr"},{"issue":"8","key":"827_CR22","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1016\/j.clinthera","volume":"31","author":"K Makarounas-Kirchmann","year":"2009","unstructured":"Makarounas-Kirchmann K, Glover-Koudounas S, Ferrari P. Results of a meta-analysis comparing the tolerability of lercanidipine and other dihydropyridine calcium channel blockers. Clin Ther. 2009;31(8):1652\u201363. https:\/\/doi.org\/10.1016\/j.clinthera. 2009.08.010 PubMed PMID: 19808126.","journal-title":"Clin Ther"},{"issue":"1","key":"827_CR23","first-page":"2","volume":"26","author":"V Barrios","year":"2008","unstructured":"Barrios V, Escobar C, De La Figuera M, Llisterri JL, Honorato J, Segura J, Calder\u00f3n A. Tolerability of high doses of lercanidipine versus high doses of other dihydropyridines in daily clinical practice: the TOLERANCE Study. Cardiovasc Ther. 2008;26(1):2\u20139. 00035.X PubMed PMID: 18466416.","journal-title":"Cardiovasc Ther"},{"issue":"10317","key":"827_CR24","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1016\/S0140-6736(","volume":"398","author":"W Ricciardi","year":"2021","unstructured":"Ricciardi W, Tarricone R, The evolution of the Italian National Health Service. Lancet. 2021;398(10317):2193\u2013206. https:\/\/doi.org\/10.1016\/S0140-6736(. 21)01733-5 PubMed PMID: 34695372.","journal-title":"Lancet"},{"issue":"10","key":"827_CR25","doi-asserted-by":"publisher","first-page":"4427","DOI":"10.1111\/bcp.15391","volume":"88","author":"LL Dalli","year":"2022","unstructured":"Dalli LL, Kilkenny MF, Arnet I, Sanfilippo FM, Cummings DM, Kapral MK, Kim J, Cameron J, Yap KY, Greenland M, Cadilhac DA. Towards better reporting of the proportion of days covered method in cardiovascular medication adherence: A scoping review and new tool TEN-SPIDERS. Br J Clin Pharmacol. 2022;88(10):4427\u201342. 10. 1111\/BCP.15391 PubMed PMID: 35524398.","journal-title":"Br J Clin Pharmacol"},{"key":"827_CR26","unstructured":"Cohen J. Statistical Power Analysis for the Behavioral Sciences. Lawrence Erlbaum Associates; 1988."},{"issue":"1","key":"827_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40545-021-00385-w","volume":"14","author":"D Prieto-Merino","year":"2021","unstructured":"Prieto-Merino D, Mulick A, Armstrong C, Hoult H, Fawcett S, Eliasson L, Clifford S. Estimating proportion of days covered (PDC) using real-world online medicine suppliers\u2019 datasets. J Pharm Policy Pract. 2021;14(1):1\u201314. https:\/\/doi.org\/10.1186\/s40545-021-00385-w.","journal-title":"J Pharm Policy Pract"},{"issue":"4","key":"827_CR28","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/S40520-013-0060-7","volume":"25","author":"F Lapi","year":"2013","unstructured":"Lapi F, Lucenteforte E, Moschini M, Bonaiuti R, Di Pirro M, Barchielli A, Benemei S, Belladonna M, Nesti N, Coppini R, Taras M, Vannacci A, Ungar A, Mugelli A. Representativeness of the Fiesole Misurata study database for use in pharmaco-epidemiological investigations on adherence to antihypertensive medications. Aging Clin Exp Res. 2013;25(4):433\u201345. https:\/\/doi.org\/10.1007\/S40520-013-0060-7 . PubMed PMID: 23780690.","journal-title":"Aging Clin Exp Res"},{"key":"827_CR29","unstructured":"Italian Medicines Agency. The Medicines Utilisation Monitoring Centre. National Report on Medicines use in Italy. Year 2024. 2025. Available from: https:\/\/www.aifa.gov.it.\u00a0[cited 2025 Nov 16]."},{"key":"827_CR30","unstructured":"Italian Medicines Agency. The Medicines Utilisation Monitoring Centre. National Report on Medicines use in Italy. Year 2024. Supplementary material. 2025."},{"issue":"8","key":"827_CR31","doi-asserted-by":"publisher","first-page":"e70108","DOI":"10.1111\/JCH.70108","volume":"27","author":"NMMA Bhuiya","year":"2025","unstructured":"Bhuiya NMMA, Caballero J, Young HN, Zapata LV. Trends and Predictors of Antihypertensive Medication Adherence in Commercially Insured Adults under 65 (2018\u20132023). J Clin Hypertens. 2025;27(8):e70108. https:\/\/doi.org\/10.1111\/JCH.70108.","journal-title":"J Clin Hypertens"},{"issue":"5","key":"827_CR32","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1097\/HJH.0000000000000130","volume":"32","author":"G Corrao","year":"2014","unstructured":"Corrao G, Soranna D, La Vecchia C, Catapano A, Agabiti-Rosei E, Gensini G, Merlino L, Mancia G. Medication persistence and the use of generic and brand-name blood pressure-lowering agents. J Hypertens. 2014;32(5):1146\u201353. 10. 1097\/HJH.0000000000000130 PubMed PMID: 24569417.","journal-title":"J Hypertens"},{"key":"827_CR33","doi-asserted-by":"publisher","unstructured":"Pruijm MT, Maillard MP, Burnier M. Patient adherence and the choice of antihypertensive drugs: focus on lercanidipine. Vasc Health Risk Manag. 2008;61159\u201366. https:\/\/doi.org\/10.2147\/vhrm.s3510.","DOI":"10.2147\/vhrm.s3510"},{"issue":"8","key":"827_CR34","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0828-282X","volume":"24","author":"C Bucci","year":"2008","unstructured":"Bucci C, Mamdani MM, Juurlink DN, Tu JV. Dihydropyridine calcium channel blockers and cardiovascular outcomes in elderly patients: A population-based study. Can J Cardiol. 2008;24(8):629\u201332. https:\/\/doi.org\/10.1016\/S0828-282X. (08)70651-2 PubMed PMID: 18685743.","journal-title":"Can J Cardiol"},{"issue":"2","key":"827_CR35","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/ajh\/hpae147","volume":"38","author":"J Jeon","year":"2025","unstructured":"Jeon J, Ryoo S, Oh S, Hong SJ, Yu CW, Kim YH, Kim EJ, Joo HJ. Comparative Effectiveness of Lercanidipine and Amlodipine on Major Adverse Cardiovascular Events in Hypertensive Patients. Am J Hypertens. 2025;38(2):139\u201347. 10.1093. \/AJH\/HPAE147 PubMed PMID: 39589752.","journal-title":"Am J Hypertens"},{"issue":"1","key":"827_CR36","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.phrs.2008.09","volume":"59","author":"JR Wu","year":"2009","unstructured":"Wu JR, Liou SF, Lin SW, Chai CY, Dai ZK, Liang JC, Chen IJ, Yeh JL. Lercanidipine inhibits vascular smooth muscle cell proliferation and neointimal formation via reducing intracellular reactive oxygen species and inactivating Ras-ERK1\/2 signaling. Pharmacol Res. 2009;59(1):48\u201356. https:\/\/doi.org\/10.1016\/j.phrs.2008.09. .015 PubMed PMID: 18973813.","journal-title":"Pharmacol Res"},{"issue":"4","key":"827_CR37","doi-asserted-by":"publisher","first-page":"238","DOI":"10.4103\/0976-500X","volume":"4","author":"P Vasigar","year":"2013","unstructured":"Vasigar P, Batmanabane M. Anti-inflammatoryactivity of calciumchannel blocker lercanidipine hydrochloride. J Pharmacol Pharmacother. 2013;4(4):238. https:\/\/doi.org\/10.4103\/0976-500X. .119707 PubMed PMID: 24250199.","journal-title":"J Pharmacol Pharmacother"},{"issue":"3","key":"827_CR38","first-page":"173","volume":"1","author":"C Borghi","year":"2005","unstructured":"Borghi C. Lercanidipine in Hypertension. Vasc Health Risk Manag. 2005;1(3):173. PubMed PMID: 17319103.","journal-title":"Vasc Health Risk Manag"},{"issue":"9502","key":"827_CR39","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1016\/S0140-6736(","volume":"366","author":"BB Granger","year":"2005","unstructured":"Granger BB, Swedberg K, Ekman I, Granger CB, Olofsson B, McMurray JJ, Yusuf S, Michelson EL, Pfeffer MA. Adherence to candesartan and placebo and outcomes in chronic heart failure in the CHARM programme: double-blind, randomised, controlled clinical trial. Lancet. 2005;366(9502):2005\u201311. https:\/\/doi.org\/10.1016\/S0140-6736(. 05)67760-4 PubMed PMID: 16338449.","journal-title":"Lancet"}],"container-title":["High Blood Pressure & Cardiovascular Prevention"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40292-026-00827-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40292-026-00827-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40292-026-00827-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T06:02:36Z","timestamp":1791957756000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40292-026-00827-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,12]]},"references-count":39,"alternative-id":["827"],"URL":"https:\/\/doi.org\/10.1007\/s40292-026-00827-z","relation":{},"ISSN":["1179-1985"],"issn-type":[{"value":"1179-1985","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,12]]},"assertion":[{"value":"30 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Approval was obtained from the ethics committees of the participating healthcare entities. Informed consent was not required for this study, as the dataset consisted of anonymised data only.","order":1,"name":"Ethics","label":"Compliance with Ethical Standards","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Authors Luca degli Esposti, Simone Leonetti and Lisa Giannessi are employees of CliCon s.r.l. Societ\u00e0 Benefit; this work is based on a study conducted by the authors from the STREAM study, an autonomous research project of CliCon. The authors retained full and independent control over the study design, the conduct and the analyses, the interpretation of the results, and the decision to publish, and declare no other competing interests. Luca Degli Esposti is the Sole Director and ultimate controlling shareholder of CliCon s.r.l. Societ\u00e0 Benefit and has had, over the past two years, financial relationships with several pharmaceutical companies.Claudio Ferri serves on the editorial board of High Blood Pressure & Cardiovascular Prevention.","order":2,"name":"Ethics","label":"Competing Interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}